# Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)

> **NCT00979940** · NA · TERMINATED · sponsor: **Indiana University** · enrollment: 60 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT00979940
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2014-06
- **Final completion:** 2014-08
- **Target enrollment:** 60 (ACTUAL)
- **Why stopped:** Slower than anticipated enrollment for pilot study.
- **Last updated:** 2015-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00979940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00979940, "Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00979940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*